Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK39775 in advanced solid malignancies
NCT06314373Phase 2Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Mar 2024
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK39775 in solid tumor (advanced stage), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Mar 2024; status: recruiting.
02
Drugs
HSK39775
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06314373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06314373.